ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/16/2025
Back to search
Official data from USPTO
AFYX THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AFYX THERAPEUTICS
ST13
US500000088279875Class
5, 42, 44
Filing
88279875
Registration
5987801
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
09/06/2025
Trademark type
Word
Nice classes
5, 42, 44
Filing date
01/28/2019
Registration date
02/18/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/18/2020
Last transaction
09/06/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
65
Owner location
H�RSHOLM, DK
Examiner
WILKE, JOHN
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
AFYX DEVELOPMENT A/S
AFYX THERAPEUTICS A/S
Dermtreat A/S
Representatives
Carolyn M. Gouges d'Agincourt Verrill Dana LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for treatment of mucosal diseases; pharmaceutical preparations and substances for treatment of mucosal diseases; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for treating mucous membrane disorders; pharmaceutical preparationsmuco adhesive patches for efficient and uniform drug release; medicine for treatment of mucosal diseases; medical preparations and articles for treatment of mucosal diseases; medical preparations and articlesmucous membrane- and skin- adhesive patches for coverage of lesions and/or efficient and uniform drug delivery; patches for treatment of mucosal diseases; adhesive patches for medical purposesnamely for treatment of mucosal diseases; skin patches for the transdermal delivery of pharmaceuticals for use in the treatment of mucosal diseases; mucous membrane patches for the transdermal delivery of pharmaceuticals for use in the treatment of mucosal diseases; transdermal patches for use in the treatment of mucosal diseases; transdermal patches for medical treatment for use in the treatment of mucosal diseases; transmucosal patches for medical treatment of mucosal diseases; dressingsmedical; adhesive dressings; dressings for wounds; bandagesmedical; adhesive bandages; bandages for skin wounds; bandages for mucous membrane wounds; mucosal surface delivery of pharmaceuticals for use in the treatment of mucosal diseases
Class 42
Scientificmedical and pharmaceutical research and development services; research and development of pharmaceutical preparations; research and development of pharmaceutical preparations for treating skin disorders; research and development of pharmaceutical preparations for treating mucous membrane disorders; research and development of pharmaceutical preparationsmuco adhesive patches for efficient and uniform drug release; research and development of medicines; research and development of medical preparations and articles; research and development of medical preparations and articlesmucous membrane- and skin- adhesive patches for coverage of lesions and/or efficient and uniform drug delivery; medical research and analysis services; biological research; clinical research in the field of treatment of mucosal diseases; scientific investigations for medical purposes; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals
Class 44
Medical services; medical treatment services; medical screening; medical monitoringtestinginspection and analysis services; medical services relating to the diagnosis and treatment of skin disorders; medical services relating to the diagnosis and treatment of mucous membrane disorders; pharmaceutical compounding services; pharmaceutical advisory services; dermatological services for treating skin conditions; dermatological services for treating mucous membrane conditions; laboratory analysis services relating to the diagnosis and treatment of skin disorders; medical laboratory analysis services provided by medical laboratories relating to the diagnosis and treatment of mucous membrane disorders
Publications
History of USPTO decisions and trademark events.
37 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/25/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/25/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/25/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/25/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/25/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/25/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
12/06/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/06/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/06/2024
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
12/06/2024
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
12/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
02/18/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
01/15/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/15/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
11/26/2019
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
11/26/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/16/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/16/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/01/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2019
PUBO
PUBLISHED FOR OPPOSITION
08/06/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/10/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
06/28/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06/21/2019
ALIE
ASSIGNED TO LIE
06/19/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/05/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/09/2019
GNRT
NON-FINAL ACTION E-MAILED
04/09/2019
CNRT
NON-FINAL ACTION WRITTEN
04/09/2019
DOCK
ASSIGNED TO EXAMINER
04/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/20/2019
NWAP
NEW APPLICATION ENTERED
01/31/2019
Continuous trademark protection
Get notified about every new filing that threatens AFYX THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.